1 |
MASP2
| [1] Staphylococcus aureus infection Staphylococcus aureus infection | D11531
D11531
|
Narsoplimab
| [4] 64 64, 66, 109, 222 |
2 |
CFD
| [1] Staphylococcus aureus infection Staphylococcus aureus infection | D11641
D11641
|
Danicopan
| [1] 62 62 |
3 |
IL10
| [7] Viral protein interaction with cytokine and cytokine receptor Viral protein interaction with cytokine and cytokine receptor, T cell receptor signaling pathway, Yersinia infection, Toxoplasmosis, Staphylococcus aureus infection, Tuberculosis, Systemic lupus erythematosus | D01583
D01583
|
Pirfenidone
| [11] 13 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 |
4 |
ITGAL
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Viral myocarditis | D03959
D03959
|
Efalizumab
| [9] 11 11, 13, 37, 46, 49, 53, 61, 95, 96 |
5 |
PLG
| [1] Staphylococcus aureus infection Staphylococcus aureus infection | D00160
D00160
|
Aminocaproic acid
| [1] 70 70 |
6 |
PLG
| [1] Staphylococcus aureus infection Staphylococcus aureus infection | D01136
D01136
|
Tranexamic acid
| [7] 46 46, 70, 215, 227, 274, 288, 299 |
7 |
PTAFR
| [1] Staphylococcus aureus infection Staphylococcus aureus infection | D07407
D07407
|
Rupatadine
| [1] 46 46 |
8 |
CFB
| [1] Staphylococcus aureus infection Staphylococcus aureus infection | D12251
D12251
|
Iptacopan
| [5] 61 61, 62, 66, 109, 222 |
9 |
C1R
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D10845
D10845
|
Conestat alfa
| [1] 61 61 |
10 |
C1S
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D10845
D10845
|
Conestat alfa
| [1] 61 61 |
11 |
C1S
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D11530
D11530
|
Sutimlimab
| [1] 61 61 |
12 |
C3
| [4] Staphylococcus aureus infection Staphylococcus aureus infection, Tuberculosis, Viral carcinogenesis, Systemic lupus erythematosus | D11613
D11613
|
Pegcetacoplan
| [4] 2 2, 61, 62, 222 |
13 |
C5
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D03940
D03940
|
Eculizumab
| [7] 11 11, 13, 14, 61, 62, 109, 222 |
14 |
C5
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D11054
D11054
|
Ravulizumab
| [7] 2 2, 11, 13, 50, 62, 66, 109 |
15 |
C5
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D11473
D11473
|
Nomacopan
| [3] 62 62, 109, 162 |
16 |
C5
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D11477
D11477
|
Pozelimab
| [2] 11 11, 62 |
17 |
C5
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D11696
D11696
|
Crovalimab
| [2] 62 62, 109 |
18 |
C5
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D11838
D11838
|
Vilobelimab
| [3] 43 43, 44, 269 |
19 |
C5
| [2] Staphylococcus aureus infection Staphylococcus aureus infection, Systemic lupus erythematosus | D12357
D12357
|
Zilucoplan
| [3] 2 2, 11, 62 |
20 |
C5AR1
| [1] Staphylococcus aureus infection Staphylococcus aureus infection | D11093
D11093
|
Avacopan
| [3] 43 43, 44, 222 |